{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:29:07Z","timestamp":1758961747928,"version":"3.32.0"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.cyto.2023.156479","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T12:02:58Z","timestamp":1704801778000},"page":"156479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Interaction between cardiac resynchronization therapy and cytokines in heart failure patients"],"prefix":"10.1016","volume":"175","author":[{"given":"Seyyed Shamsadin","family":"Athari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Entezar","family":"Mehrabi Nasab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2023.156479_b0005","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/CIRCRESAHA.113.300268","article-title":"Epidemiology of heart failure","volume":"113","author":"Roger","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.cyto.2023.156479_b0010","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/heart.83.5.505","article-title":"Survival of patients with a new diagnosis of heart failure: a population based study","volume":"83","author":"Cowie","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.cyto.2023.156479_b0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000338166","article-title":"Inflammatory Cytokines in Heart Failure: Mediators and Markers","volume":"122","author":"Gullestada","year":"2012","journal-title":"Cardiology"},{"key":"10.1016\/j.cyto.2023.156479_b0020","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/cvr\/cvz232","article-title":"Cardiac resynchronization therapy reduces expression of inflammation-promoting genes related to interleukin-1b in heart failure","volume":"116","author":"Bilchick","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cyto.2023.156479_b0025","doi-asserted-by":"crossref","first-page":"e003688","DOI":"10.1161\/CIRCHEARTFAILURE.116.003688","article-title":"Activated T lymphocytes are essential drivers of pathological remodeling in ischemic heart failure","volume":"10","author":"Bansal","year":"2017","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.cyto.2023.156479_b0030","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/CIRCRESAHA.117.311071","article-title":"Resident and monocyte-derived macrophages in cardiovascular disease","volume":"122","author":"Honold","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.cyto.2023.156479_b0035","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nri3800","article-title":"Role of innate and adaptive immune mechanisms in cardiac injury and repair","volume":"15","author":"Epelman","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2023.156479_b0040","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/ejhf.942","article-title":"Immune mechanisms in heart failure","volume":"19","author":"Zhang","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.cyto.2023.156479_b0045","doi-asserted-by":"crossref","first-page":"381","DOI":"10.7326\/0003-4819-141-5-200409070-00101","article-title":"Systematic review: cardiac resynchronization in patients with symptomatic heart failure","volume":"141","author":"McAlister","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cyto.2023.156479_b0050","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jacc.2008.08.027","article-title":"Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dys-function and previous heart failure symptoms","volume":"52","author":"Linde","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cyto.2023.156479_b0055","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1503\/cmaj.101685","article-title":"Cardiac resynchronization therapy: a meta-analysis of randomized controlled trials","volume":"183","author":"Wells","year":"2011","journal-title":"CanMed Assoc J."},{"key":"10.1016\/j.cyto.2023.156479_b0060","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/CIRCULATIONAHA.108.793273","article-title":"Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION)trial","volume":"119","author":"Anand","year":"2009","journal-title":"Circulation"},{"doi-asserted-by":"crossref","unstructured":"Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, Cleland J, Deharo JC, Delgado V, Elliott PM, et al; ESC Committee for Practice Guidelines (CPG); Document Reviewers. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: themTask Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J. 2013; 34:2281-2329.","key":"10.1016\/j.cyto.2023.156479_b0065","DOI":"10.1093\/eurheartj\/eht150"},{"issue":"9","key":"10.1016\/j.cyto.2023.156479_b0070","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1161\/CIRCULATIONAHA.108.794834","article-title":"Electrophysiological consequences of dyssynchronous heart failure and its restoration by resynchronization therapy","volume":"119","author":"Aiba","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2023.156479_b0075","article-title":"G\u03b1s-biased \u03b22- adrenergic receptor signaling from restoring synchronous contraction in the failing heart","volume":"3(100):100ra88","author":"Chakir","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cyto.2023.156479_b0080","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/sji.12328","article-title":"Effect of cardiac resynchronization therapy on inflammation in congestive heart failure: a review","volume":"82","author":"Lappegard","year":"2015","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.cyto.2023.156479_b0085","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.clinbiochem.2012.11.002","article-title":"Cardiac resynchronization therapy in patients with chronic heart failure is associated with anti-inflammatory and anti-remodeling effects","volume":"46","author":"Stanciu","year":"2013","journal-title":"Clin. Biochem."},{"issue":"7","key":"10.1016\/j.cyto.2023.156479_b0090","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jacc.2008.10.041","article-title":"Acute heart failure syndromes","volume":"53","author":"Gheorghiade","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"doi-asserted-by":"crossref","unstructured":"P. Ponikowski, A.A. Voors, S.D. Anker, H. Bueno, J.G. Cleland, A.J. Coats, V. Falk, J.R. Gonz\u00e1lez-Juanatey, V.P. Harjola, E.A. Jankowska, M. Jessup, C. Linde, P. Nihoyannopoulos, J.T. Parissis, B. Pieske, J.P. Riley, G.M. Rosano, L.M. Ruilope, F. Ruschitzka, F.H.Rutten, P. van derMeer, Authors\/Task ForceMembers; Document Reviewers, ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the heart failure association (HFA) of the ESC, Eur. J. Heart Fail. 2016; 18:891\u2013975.","key":"10.1016\/j.cyto.2023.156479_b0095","DOI":"10.1002\/ejhf.592"},{"key":"10.1016\/j.cyto.2023.156479_b0100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"ACCF\/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cyto.2023.156479_b0105","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1161\/ATVBAHA.111.224915","article-title":"Mechanisms of cell death in heart disease","volume":"32","author":"Konstantinidis","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cyto.2023.156479_b0110","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2174\/1389202916999150120153344","article-title":"Heart failure in chronic myocarditis: a role for microRNAs? Curr","volume":"16","author":"van den Hoogen","year":"2015","journal-title":"Genomics"},{"key":"10.1016\/j.cyto.2023.156479_b0115","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/1358836X9800300309","article-title":"The interface of atherosclerosis and thrombosis: basic mechanisms","volume":"3","author":"Libby","year":"1998","journal-title":"Vasc. Med."},{"key":"10.1016\/j.cyto.2023.156479_b0120","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJM199007263230405","article-title":"Elevated circulating levels of tumor necrosis factor in severe chronic heart failure","volume":"223","author":"Levine","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2023.156479_b0125","doi-asserted-by":"crossref","DOI":"10.1002\/ehf2.14111","article-title":"IL-33\/ST2 pathway as upper-hand of inflammation in allergic asthma contributes as predictive biomarker in heart failure","author":"Mehrabi Nasab","year":"2022","journal-title":"ESC Heart Failure"},{"key":"10.1016\/j.cyto.2023.156479_b0130","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/CIRCRESAHA.116.302317","article-title":"Innate immunity and the failing heart: the cytokine hypothesis revisited","volume":"116","author":"Mann","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.cyto.2023.156479_b0135","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/CIRCULATIONAHA.117.027551","article-title":"Trends in hospitalizations and survival of acute decompensated heart failure in four US communities (2005\u20132014): ARIC study community surveillance","volume":"138","author":"Chang","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2023.156479_b0140","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11897-008-0005-1","article-title":"Effects of cardiac resynchronization therapy on ventricular remodeling","volume":"5","author":"Rahmouni","year":"2008","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.cyto.2023.156479_b0145","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.ejheart.2007.07.007","article-title":"Reverse ventricular remodeling after cardiac resynchronization therapy is associated with a reduction in serum tenascin-C and plasma matrix metalloproteinase-9 levels","volume":"9","author":"Hessel","year":"2007","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.cyto.2023.156479_b0150","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1373\/clinchem.2011.165720","article-title":"Emerging biomarkers in heart failure","volume":"58","author":"Van Kimmenade","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cyto.2023.156479_b0155","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/A:1011428824771","article-title":"The role of interleukin-1 in the failing heart","volume":"6","author":"Long","year":"2001","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.cyto.2023.156479_b0160","first-page":"1139","article-title":"IL-1 stimulates rat cardiac fibroblast migration via MAP kinase pathways","volume":"292","author":"Mitchell","year":"2007","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"key":"10.1016\/j.cyto.2023.156479_b0165","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/eurheartj\/ehl505","article-title":"Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony","volume":"28","author":"Fruhwald","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cyto.2023.156479_b0170","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jaci.2010.11.050","article-title":"Interleukins, from, 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases","volume":"127","author":"Akdis","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cyto.2023.156479_b0175","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1002\/eji.200737772","article-title":"Historical review of cytokines","volume":"37","author":"Dinarello","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2023.156479_b0180","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10741-006-9196-2","article-title":"Aukrust, Systemic inflammation in heart failure\u2013the whys and wherefores","volume":"11","author":"Yndestad","year":"2006","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.cyto.2023.156479_b0185","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/ejhf.203","article-title":"Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trial","volume":"17","author":"Edelmann","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.cyto.2023.156479_b0190","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.transproceed.2009.06.009","article-title":"decreased expression of thrombospondin-1 in failing hearts may favor ventricular remodeling","volume":"41","author":"Batlle","year":"2009","journal-title":"Transpl. Proc."},{"key":"10.1016\/j.cyto.2023.156479_b0195","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCULATIONAHA.112.150656","article-title":"Cardiokines: recent progress in elucidating the cardiac secretome","volume":"126","author":"Shimano","year":"2012","journal-title":"Circulation"},{"issue":"suppl I","key":"10.1016\/j.cyto.2023.156479_b0200","doi-asserted-by":"crossref","first-page":"i90","DOI":"10.1136\/ard.59.suppl_1.i90","article-title":"Activation of cytokines as a mechanism of disease progression in heart failure","volume":"59","author":"Bozkurt","year":"2000","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2023.156479_b0205","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0002-9149(96)00063-X","article-title":"Circulating interleukin-6 in severe heart failure","volume":"79","author":"MacGowan","year":"1997","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.cyto.2023.156479_b0210","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/0735-1097(95)00589-7","article-title":"Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD)","volume":"27","author":"Torre-Amione","year":"1996","journal-title":"Jam Coll Cardiol"},{"key":"10.1016\/j.cyto.2023.156479_b0215","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0735-1097(96)00268-9","article-title":"Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension","volume":"28","author":"Testa","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cyto.2023.156479_b0220","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1161\/01.CIR.92.6.1479","article-title":"Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure","volume":"92","author":"Ferrari","year":"1995","journal-title":"Circulation"},{"doi-asserted-by":"crossref","unstructured":"Hirano T. Interleukin-6. In: Thompson A, ed. The cytokine handbook. Boston: Academic Press, Van Tassell BW, Canada J, Carbone S, Trankle C, Buckley L, Oddi Erdle C, Abouzaki NA, Dixon D, Kadariya D, Christopher S, Schatz A, Regan J, Viscusi M, Del Buono M, Melchior R, Mankad P, Lu J, Sculthorpe R, Biondi-Zoccai G, Lesnefsky E, Arena R, Abbate A. Interleukin-1 blockade in recently decompensated systolic heart failure: results from REDHART (Recently Decompensated Heart Failure Anakinra Response Trial). Circ Heart Fail 2017; 10.1991:169\u201390.","key":"10.1016\/j.cyto.2023.156479_b0225","DOI":"10.1161\/CIRCHEARTFAILURE.117.004373"},{"key":"10.1016\/j.cyto.2023.156479_b0230","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.amjcard.2018.07.002","article-title":"Usefulness of canakinumab to improve exercise capacity in patients with long-term systolic heart failure and elevated C-reactive protein","volume":"122","author":"Trankle","year":"2018","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.cyto.2023.156479_b0235","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40119-018-0104-3","article-title":"A review of interleukin-1 in heart disease: where do we stand today?","volume":"7","author":"Szekely","year":"2018","journal-title":"Cardiol Ther"},{"key":"10.1016\/j.cyto.2023.156479_b0240","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2023.156479_b0245","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(17)32814-3","article-title":"Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial","volume":"391","author":"Ridker","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2023.156479_b0250","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2119\/2007-00071.Rohrbach","article-title":"Activation of AP-1 contributes to the beta-adrenoceptor-mediated myocardial induction of interleukin-6","volume":"13","author":"Rohrbach","year":"2007","journal-title":"Mol. Med."},{"key":"10.1016\/j.cyto.2023.156479_b0255","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1006\/jmcc.1999.1033","article-title":"Increased JNK, AP-1 and NF-kappa B DNA binding activities in isoproterenol-induced cardiac remodeling","volume":"31","author":"Takemoto","year":"1999","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.cyto.2023.156479_b0260","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4049\/jimmunol.1401595","article-title":"JUNB is a key transcriptional modulator of macrophage activation","volume":"194","author":"Fontana","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2023.156479_b0265","doi-asserted-by":"crossref","first-page":"e73294","DOI":"10.1371\/journal.pone.0073294","article-title":"The AP-1 transcription factor c-Jun prevents stress-imposed maladaptive remodeling of the heart","volume":"8","author":"Windak","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2023.156479_b0270","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0008-6363(02)00723-X","article-title":"Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure","volume":"57","author":"Frantz","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cyto.2023.156479_b0275","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.yjmcc.2016.08.018","article-title":"Regulation of cardiac hypertrophy and remodeling through the dual-specificity MAPK phosphatases (DUSPs)","volume":"101","author":"Liu","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.cyto.2023.156479_b0280","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.4049\/jimmunol.176.3.1899","article-title":"Essential role of MAPK phosphatase-1 in the negative control of innate immune responses","volume":"176","author":"Salojin","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2023.156479_b0285","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3892\/ijmm.2015.2104","article-title":"Mitogen-activated protein kinase phosphatase-1: a critical phosphatase manipulating mitogen-activated protein kinase signaling in cardiovascular disease (review)","volume":"35","author":"Li","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.cyto.2023.156479_b0290","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nri2035","article-title":"MAPK phosphatases\u2013regulating the immune response","volume":"7","author":"Liu","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2023.156479_b0295","doi-asserted-by":"crossref","first-page":"e39811","DOI":"10.1371\/journal.pone.0039811","article-title":"IL-1beta signals through the EGF receptor and activates Egr-1 through MMP-ADAM","volume":"7","author":"Sanchez-Guerrero","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2023.156479_b0300","doi-asserted-by":"crossref","first-page":"12120","DOI":"10.1074\/jbc.M800583200","article-title":"Transcriptional regulation of EGR-1 by the interleukin-1-JNK-MKK7-c-Jun pathway","volume":"283","author":"Hoffmann","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"8 Suppl","key":"10.1016\/j.cyto.2023.156479_b0305","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.hrthm.2012.04.026","article-title":"Cardiac resynchronization therapy (CRT): Clinical trials, guidelines, and target populations","volume":"9","author":"Linde","year":"2012","journal-title":"Heart Rhythm Society."},{"key":"10.1016\/j.cyto.2023.156479_b0310","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa013168","article-title":"Cardiac resynchronization in chronic heart failure","volume":"346","author":"Abraham","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2023.156479_b0315","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2023.156479_b0320","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Car- diac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2023.156479_b0325","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1161\/01.CIR.41.6.899","article-title":"Total excitation of the isolated human heart","volume":"41","author":"Durrer","year":"1970","journal-title":"Circulation"},{"issue":"Suppl 3","key":"10.1016\/j.cyto.2023.156479_b0330","first-page":"88","article-title":"Echocardiographic optimization of the atrioventricular and interventricular intervals during cardiac resynchronization","volume":"10","author":"Barold","year":"2008","journal-title":"Europace"},{"key":"10.1016\/j.cyto.2023.156479_b0335","first-page":"H428","article-title":"Influence of pacing site on canine left ventricular contraction","volume":"251","author":"Burkhoff","year":"1986","journal-title":"Am. J. Phys. Anthropol."},{"key":"10.1016\/j.cyto.2023.156479_b0340","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/01.RES.57.5.706","article-title":"Effect of alteration of left ventricular activation sequence on the left ventricular end-systolic pressure-volume relation in closed-chest dogs","volume":"57","author":"Park","year":"1985","journal-title":"Circ. Res."},{"key":"10.1016\/j.cyto.2023.156479_b0345","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0735-1097(03)00257-2","article-title":"Cardiac resynchronization therapy homogenizes myocardial glucose metabolism and perfusion in dilated cardiomyopathy and left bundle branch block","volume":"41","author":"Nowak","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cyto.2023.156479_b0350","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0008-6363(01)00513-2","article-title":"Relation between local myocardial growth and blood flow during chronic ventricular pacing","volume":"53","author":"Van Oosterhout","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cyto.2023.156479_b0355","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/eurheartj\/ehi046","article-title":"Effect of cardiac resynchronization therapy on global and regional oxygen consumption and myocardial blood flow in patients with nonischaemic and ischaemic cardiomyopathy","volume":"26","author":"Lindner","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cyto.2023.156479_b0360","first-page":"H300","article-title":"Redistribution of myocardial fiber strain and blood flow by asynchronous activation","volume":"259","author":"Prinzen","year":"1990","journal-title":"Am. J. Phys. Anthropol."},{"issue":"Pt 3","key":"10.1016\/j.cyto.2023.156479_b0365","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1113\/jphysiol.1994.sp020209","article-title":"Regional fibre stress-fibre strain area as estimate of regional oxygen demand in the canine heart","volume":"477","author":"Delhaas","year":"1994","journal-title":"J. Physiol."},{"key":"10.1016\/j.cyto.2023.156479_b0370","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/eurheartj\/ehi008","article-title":"Left bundle branch block induces ventricular remodelling and functional septal hypoperfusion","volume":"26","author":"Vernooy","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cyto.2023.156479_b0375","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1161\/01.RES.73.2.379","article-title":"Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure","volume":"73","author":"Beuckelmann","year":"1993","journal-title":"Circ. Res."},{"key":"10.1016\/j.cyto.2023.156479_b0380","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1152\/physrev.00014.2006","article-title":"Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation","volume":"87","author":"Nattel","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cyto.2023.156479_b0385","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1161\/01.RES.0000092248.59479.AE","article-title":"Transmural electrophysiological heterogeneities underlying arrhythmogenesis in heart failure","volume":"93","author":"Akar","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.cyto.2023.156479_b0390","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1161\/CIRCULATIONAHA.105.552968","article-title":"Potassium channel subunit remodeling in rabbits exposed to long-term bradycardia or tachycardia: discrete arrhythmogenic consequences related to differential delayed-rectifier changes","volume":"113","author":"Tsuji","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2023.156479_b0395","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","article-title":"Car- diac-resynchronization therapy for the prevention of heart-failure events","volume":"361","author":"Moss","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2023.156479_b0400","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1009540","article-title":"Car- diac-resynchronization therapy for mild-to-moderate heart failure","volume":"363","author":"Tang","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2023.156479_b0405","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jjcc.2021.10.021","article-title":"Cardiac resynchronization therapy: Current status and near-future prospects","volume":"79","author":"Nakai","year":"2022","journal-title":"J. Cardiol."},{"issue":"8","key":"10.1016\/j.cyto.2023.156479_b0410","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/j.1540-8159.2007.00803.x","article-title":"Integrating functional and anatomical information to facilitate cardiac resynchronization therapy","volume":"30","author":"Tournoux","year":"2007","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.cyto.2023.156479_b0415","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/0002-9343(56)90204-2","article-title":"Mechanisms of QRS complex prolongation in man; left ventricular conduction disturbances","volume":"20","author":"Grant","year":"1956","journal-title":"Am. J. Med."},{"unstructured":"J.L. Willems, J.H. Van Bemmel, C. Zywietz, (eds.), Computer ECG Analysis: Toward Standardization. Amsterdam, The Netherlands: North Holland; 1986: pp 221-272.","key":"10.1016\/j.cyto.2023.156479_b0420"},{"year":"2008","author":"Wagner","series-title":"Marriott\u2019s Practical Electrocardiograpy","key":"10.1016\/j.cyto.2023.156479_b0425"},{"key":"10.1016\/j.cyto.2023.156479_b0430","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ehj.2003.09.030","article-title":"Interventricular and intraventricular dyssynchrony are common in heart failure patients, regardless of QRS duration","volume":"25","author":"Ghio","year":"2004","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cyto.2023.156479_b0435","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jcmg.2009.08.012","article-title":"Echocardiographic dyssynchrony and health status outcomes from cardiac resynchronization therapy: Insights from the PROSPECT trial","volume":"3","author":"Chan","year":"2010","journal-title":"J. Am. Coll. Cardiol. Img."},{"key":"10.1016\/j.cyto.2023.156479_b0440","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1253\/circj.CJ-11-0774","article-title":"Tissue Doppler imaging dyssynchrony parameter derived from the myocardial active wall motion improves prediction of responders for cardiac resynchronization therapy","volume":"76","author":"Sakamaki","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.cyto.2023.156479_b0445","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0735-1097(00)00795-6","article-title":"Biventricular pacing diminishes the need for implantable cardioverter defibrillator therapy. Ventak CHF Investigators","volume":"36","author":"Higgins","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cyto.2023.156479_b0450","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/eurheartj\/ehl099","article-title":"Longer-term effects of cardiac resynchronization therapy on mortality in heart failure","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cyto.2023.156479_b0455","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.jacc.2008.07.043","article-title":"InSync\/InSync ICD Italian Registry Investigators. Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy: the InSync ICD (Implantable Cardioverter-Defibrillator) Italian Registry","volume":"52","author":"Di Biase","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cyto.2023.156479_b0460","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1540-8167.2008.01317.x","article-title":"Relationship of reverse anatomical remodeling and ventricular arrhythmias after cardiac resynchronization","volume":"20","author":"Markowitz","year":"2009","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.cyto.2023.156479_b0465","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/eurheartj\/ehs334","article-title":"Left ventricular lead location and the risk of ventricular arrhythmias in the MADIT- CRT trial","volume":"34","author":"Kutyifa","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cyto.2023.156479_b0470","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1016\/j.jacc.2005.08.035","article-title":"Potential proarrhythmic effects of biventricular pacing","volume":"46","author":"Fish","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cyto.2023.156479_b0475","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1253\/circj.CJ-14-0023","article-title":"Tumor necrosis factor-\u03b1 predicts response to cardiac resynchronization therapy in patients with chronic heart failure","volume":"78","author":"Rordorf","year":"2014","journal-title":"Circ J"},{"key":"10.1016\/j.cyto.2023.156479_b0480","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1540-8159.2006.00331.x","article-title":"Antiinflammatory effects of cardiac resynchronization therapy in patients with chronic heart failure","volume":"29","author":"Teodorakis","year":"2006","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.cyto.2023.156479_b0485","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1536\/ihj.53.306","article-title":"High sensitivity C-reactive protein predicts nonresponders and cardiac deaths in severe heart failure patients after CRT implantation","volume":"53","author":"Kamioka","year":"2012","journal-title":"Int. Heart J."},{"key":"10.1016\/j.cyto.2023.156479_b0490","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1161\/01.CIR.102.9.1027","article-title":"Biventricular pacing decreases sympathetic activity compared with right ventricular pacing in patients with depressed ejection fraction","volume":"102","author":"Hamdan","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2023.156479_b0495","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1161\/CIRCGENETICS.109.871236","article-title":"Modulation of mitochondrial proteome and improved mitochondrial function by biventricular pacing of dyssynchronous failing hearts","volume":"3","author":"Agnetti","year":"2010","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.cyto.2023.156479_b0500","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart-an engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2023.156479_b0505","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1172\/JCI57426","article-title":"Creatine kinase-mediated improvement of function in failing mouse hearts provides causal evidence the failing heart is energy starved","volume":"122","author":"Gupta","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2023.156479_b0510","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1161\/CIRCHEARTFAILURE.110.959858","article-title":"Cardiac sympathetic reserve and response to cardiac resynchronization therapy","volume":"4","author":"Cha","year":"2011","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.cyto.2023.156479_b0515","first-page":"H2647","article-title":"Sympathetic control after cardiac resynchronization therapy: responders versus nonresponders","volume":"291","author":"Najem","year":"2006","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"key":"10.1016\/j.cyto.2023.156479_b0520","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1161\/CIRCULATIONAHA.110.955039","article-title":"Effect of cardiacresynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implanta-tion trial: cardiac resynchronization therapy","volume":"122","author":"Solomon","year":"2010","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.cyto.2023.156479_b0525","first-page":"251","article-title":"The mechanisms underlying Helicobacter Pylori-mediated protection against allergic asthma","volume":"16","author":"Bagheri Lankarani","year":"2017","journal-title":"Tanaffos"},{"doi-asserted-by":"crossref","unstructured":"S\u00edlvia Martins, Nat\u00e1lia Ant\u00f3nio, Tiago Carvalheiro, Paula Laranjeira, Ricardo Rodrigues, Lino Gon\u00e7alves, C\u00e2ndida Tomaz & Artur Paiva. Reduced numbers of regulatory T cells in chronic heart failure seems not to be restored by cardiac resynchronization therapy. BMC Cardiovascular Disorders 2023; 23, Article number: 89.","key":"10.1016\/j.cyto.2023.156479_b0530","DOI":"10.1186\/s12872-023-03109-x"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466623003575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466623003575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T10:11:15Z","timestamp":1736417475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466623003575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":106,"alternative-id":["S1043466623003575"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156479","relation":{},"ISSN":["1043-4666"],"issn-type":[{"type":"print","value":"1043-4666"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interaction between cardiac resynchronization therapy and cytokines in heart failure patients","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156479","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"156479"}}